Rating Change
Citigroup reiterated its Neutral rating on Hims & Hers Health, Inc. (NYSE:HIMS) on August 11, 2026.
reiterateNYSE:HIMS
Citigroup Reiterates Neutral Rating on Hims & Hers Health, Inc. (HIMS)
Citigroup reiterated its Neutral rating on Hims & Hers Health, Inc. (NYSE:HIMS) on August 11, 2026.
At publication ·
What changed
Hims & Hers Health, Inc. (NYSE:HIMS) · reiterate
- Firm
- Citigroup
- Rating
- Neutral to Neutral
- Price at event
- $30.51
- Market capitalization
- $8.3B
At a glance
Key takeaways
- Citigroup reiterated a Neutral rating on Hims & Hers Health (HIMS) on August 11, 2026, with the stock trading at $30.51 and a market capitalization of $8.3 billion.
Market Context
Hims & Hers Health, Inc. operates in the Healthcare sector. The stock currently trades at $30.51 with a market capitalization of $8.3B. The stock has declined 37.8% over the past 52 weeks.
Analyst coverage from Citigroup provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Hims & Hers Health, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Hims & Hers Health, Inc.
Among the 10 most recent ratings: 2 Buy, 8 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 11, 2026 | Morgan Stanley | Equal-Weight | N/A |
| Aug 11, 2026 | TD Cowen | Hold | N/A |
| Aug 11, 2026 | B of A Securities | Neutral | N/A |
| Aug 11, 2026 | Deutsche Bank | Hold | N/A |
| Aug 11, 2026 | Citigroup | Neutral | N/A |
Related Tools: Analyst Ratings Dashboard | View HIMS Stock Page
Frequently Asked Questions
What does the Neutral rating mean for HIMS?
A rating of Neutral from Citigroup reflects the analyst's outlook on Hims & Hers Health, Inc. (NYSE:HIMS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HIMS forecast page.